logo
Plus   Neg
Share
Email

Althea Group Signs Medicinal Cannabis Supply Deal With UK's Grow Pharma

Althea Group Holdings said Tuesday it has entered into a medicinal cannabis supply deal with UK-based Grow Pharma to import, sell and distribute Althea products in the UK. Althea Group is an Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis.

Grow Pharma, a joint venture of Grow Biotech PLC and IPS Pharma, is an independent UK distributor of cannabis-based products for medicinal use in humans or CBPMs.
Under the agreement between the two companies, Althea's full suite of medical cannabis products will be added to the Grow Pharma formulary.

Grow Pharma has agreed to a wholesale purchase price for Althea products and has also committed to not exceed the maximum retail price of Althea products in the UK.

Althea Group noted that the deal with Grow Pharma will further expand its presence in the UK by adding new prescribers, patients, and supplementary revenue.

"With approximately 90,000 specialists in the UK, the agreement with Grow Pharma provides Althea with additional channels for patient access and more prescriber coverage, accelerating the growth of our brand," said Althea CEO Joshua Fegan.

Althea Group said its growth in the UK has been supported by the ongoing education of UK Healthcare Professionals via its infield Medical Science Liaisons team, and Althea Concierge, a free online platform that provides doctors with all the education and support tools they require to prescribe CBPMs.

In addition to its existing distribution network in the UK, including multiple medical cannabis clinics, Grow Pharma offers a direct-to-patient home delivery of prescriptions at no additional cost.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT